Singapore markets open in 3 hours 56 minutes

STRATA Skin Sciences, Inc. (SSKN)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.3857-0.0079 (-2.01%)
At close: 04:00PM EDT
0.4116 +0.03 (+6.72%)
After hours: 04:38PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.3936
Open0.4200
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.3854 - 0.4273
52-week range0.2600 - 1.0800
Volume30,290
Avg. volume28,051
Market cap13.523M
Beta (5Y monthly)1.54
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • GlobeNewswire

    STRATA Skin Sciences Reports First Quarter 2024 Financial Results and Provides a Corporate Update

    HORSHAM, Penn., May 15, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces its financial results for the quarter ended March 31, 2024 and provides a corporate update. First Quarter 2024 Highlights Revenue in the first quarter of 2024 was $6.8 million (-11% YOY) vs. $7.6 million in the first qu

  • GlobeNewswire

    STRATA Skin Sciences Surpasses 100 Domestic Installations of TheraClear®X Devices as of March 31, 2024

    HORSHAM, Pa., May 14, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces its installed base of TheraClear®X devices surpassed 100 at the end of the first quarter of 2024. As Strata is focused on expanding its TheraClear®X placements within existing XTRAC® partner clinics, a number of the devic

  • GlobeNewswire

    STRATA Skin Sciences to Participate in the Benchmark Healthcare House Call Virtual 1x1 Investor Conference

    HORSHAM, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that Dr. Dolev Rafaeli, President and Chief Executive Officer, and Christopher Lesovitz, Chief Financial Officer, will participate in the Benchmark Healthcare House Call Virtual 1x1 Investor Conference being held on May 2